Viewing Study NCT00754351


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-03-09 @ 7:04 AM
Study NCT ID: NCT00754351
Status: COMPLETED
Last Update Posted: 2012-06-28
First Post: 2008-09-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
Sponsor: University Hospital of Crete
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module